Proficio Capital Partners LLC Buys Shares of 14,995 Phreesia, Inc. (NYSE:PHR)

Proficio Capital Partners LLC purchased a new position in Phreesia, Inc. (NYSE:PHR - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 14,995 shares of the company's stock, valued at approximately $377,000.

A number of other hedge funds have also made changes to their positions in the stock. Champlain Investment Partners LLC lifted its position in shares of Phreesia by 4.1% in the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company's stock worth $57,062,000 after purchasing an additional 97,847 shares in the last quarter. Franklin Resources Inc. lifted its position in shares of Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company's stock worth $31,495,000 after purchasing an additional 42,973 shares in the last quarter. State Street Corp lifted its position in shares of Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company's stock worth $30,256,000 after purchasing an additional 88,517 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company's stock worth $28,397,000 after purchasing an additional 55,934 shares in the last quarter. Finally, TimesSquare Capital Management LLC lifted its position in shares of Phreesia by 2.3% in the third quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company's stock worth $19,791,000 after purchasing an additional 19,395 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Analysts Set New Price Targets

A number of analysts have recently issued reports on PHR shares. Piper Sandler reissued an "overweight" rating and issued a $33.00 price target (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Canaccord Genuity Group raised their price objective on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research report on Thursday. Citigroup raised their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a "buy" rating in a research report on Friday, January 10th. Robert W. Baird cut their price objective on shares of Phreesia from $34.00 to $30.00 and set an "outperform" rating on the stock in a research report on Wednesday, December 11th. Finally, KeyCorp raised their price objective on shares of Phreesia from $28.00 to $30.00 and gave the company an "overweight" rating in a research report on Wednesday, January 8th. Thirteen research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Phreesia presently has a consensus rating of "Buy" and an average price target of $31.23.

Insider Buying and Selling at Phreesia

In related news, COO Evan Roberts sold 2,873 shares of Phreesia stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $76,450.53. Following the completion of the sale, the chief operating officer now directly owns 779,993 shares in the company, valued at $20,755,613.73. This trade represents a 0.37 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Balaji Gandhi sold 3,195 shares of Phreesia stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $85,018.95. Following the completion of the sale, the chief financial officer now owns 148,509 shares of the company's stock, valued at approximately $3,951,824.49. The trade was a 2.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 163,322 shares of company stock valued at $4,631,915. 5.80% of the stock is currently owned by company insiders.

Phreesia Stock Performance

PHR traded down $0.08 during trading on Friday, reaching $25.37. 804,595 shares of the company's stock were exchanged, compared to its average volume of 432,702. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The business has a 50 day moving average price of $27.32 and a 200 day moving average price of $24.00. The company has a market capitalization of $1.47 billion, a P/E ratio of -17.26 and a beta of 1.03.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping analysts' consensus estimates of ($0.29) by $0.04. The firm had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business's revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.58) earnings per share. As a group, analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.